Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018;2018(Pt II):252-279.
doi: 10.24820/ark.5550190.p010.281. Epub 2017 Dec 21.

When nucleoside chemistry met hypervalent iodine reagents

Affiliations

When nucleoside chemistry met hypervalent iodine reagents

Mahesh K Lakshman et al. ARKIVOC. 2018.

Abstract

There has been increasing use of hypervalent iodine reagents in the field of nucleoside chemistry. Applications span: (a) synthesis of nucleoside analogues with sulfur and seleno sugar surrogates, (b) synthesis of unusual carbocyclic and ether ring-containing nucleosides, (c) introduction of sulfur and selenium into pyrimidine bases of nucleosides and analogues, (d) synthesis of isoxazole and isoxazoline ring-containing nucleoside analogues, (e) involvement of purine ring nitrogen atoms for remote C-H bond oxidation, and (f) metal-catalyzed and uncatalyzed synthesis of benzimidazolyl purine nucleoside analogues by intramolecular C-N bond formation. This review offers a perspective on developments involving the use of hypervalent iodine reagents in the field of nucleoside chemistry that have appeared in the literature in the 2003-2017 time frame.

Keywords: C-H bond activation; C-N bond formation; hypervalent iodine; nucleoside analogs; nucleosides.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The eight naturally occurring nucleosides
Figure 2
Figure 2
Commonly encountered λ3 and λ5 hypervalent iodine reagents
Figure 3
Figure 3
Possible thionium cations that are proposed in the reactions
Figure 4
Figure 4
Examples of isoxazoline-substituted 6-pyrrolidinyl purine derivatives via PIFA oxidation
Figure 5
Figure 5
Oxidation of 6-aryl purine nucleosides with Pd(OAc)2 and PIDA (PG = t-BuMe2Si)
Figure 6
Figure 6
Diacetoxylation of 6-aryl purine nucleosides with Pd(OAc)2 and PIDA (PG = t-BuMe2Si)
Figure 7
Figure 7
N6-biarylyl adenine nucleoside substrates used for the reactions involving Pd(OAc)2/PIDA (in cases where reaction was observed, red arrows indicate the site of C–N bond formation and the ensuing carbazolyl product yields are shown)
Figure 8
Figure 8
Products obtained in the fluorinated solvents in the absence of any catalyst
Scheme 1
Scheme 1
Synthesis of a higher order thymine nucleoside analogue and a plausible mechanism
Scheme 2
Scheme 2
Synthesis of a thio analogue of uridine
Scheme 3
Scheme 3
Reactions of three purines with a tetrahydrothiophenediol dibenzoate
Scheme 4
Scheme 4
Reactions of 6-chloropurine with differentially protected tetrahydothiophene derivatives
Scheme 5
Scheme 5
Testing the hypothesis on the role of protecting groups on sites of reactions
Scheme 6
Scheme 6
Formation of a tetrahydrothiophene nucleoside analogue from a thietane
Scheme 7
Scheme 7
Isomerization of cis32 and a mechanism for the formation of product 33
Scheme 8
Scheme 8
Synthesis of seleno analogues of uridine and cytidine
Scheme 9
Scheme 9
Synthesis of the seleno analogue of 6-chloropurine riboside
Scheme 10
Scheme 10
Reactions of seleno sugar analogue 40 with 2-amino-6-chloro and 2,6-dichloropurines, and further transformations to a protected seleno guanosine analogue
Scheme 11
Scheme 11
Reactions of silyl derivatives of cyclopentene and cyclohexene with uracil
Scheme 12
Scheme 12
Synthesis of cyclohexenyl uridine analogues
Scheme 13
Scheme 13
Synthesis of four isomeric cytidine nucleoside analogues
Scheme 14
Scheme 14
Reactions of dihydropyran and dihydrofuran with bis(trimethylsilyl)uracil
Scheme 15
Scheme 15
Various uracil derivatives prepared via the “seleno-glycosylation” approach and a possible mechanism
Scheme 16
Scheme 16
Synthesis of dihydropyranyl uracil nucleoside analogues
Scheme 17
Scheme 17
Separation of the uracil nucleoside analogues and conversion to the cytosine derivatives
Scheme 18
Scheme 18
Sulfenylation and selenation of uracil derivatives and uridine nucleosides, and analogues
Scheme 19
Scheme 19
Use of PIFA for the cycloaddition of nitrile oxides with alkynes
Scheme 20
Scheme 20
Formation of isoxazolyl 6-pyrrolidinyl purine derivatives by PIFA oxidation
Scheme 21
Scheme 21
Acetoxylation of an acetate-protected 6-phenyl purine ribonucleoside
Scheme 22
Scheme 22
An isolated and cystallographically characterized cyclopalladated, PdII–PdII dimer, and its potential conversion to a PdIII–PdIII species by PIDA
Scheme 23
Scheme 23
PIDA/Cu(OTf)2-mediated cyclization of N6-aryl adenosine triacetate derivatives to benzimidazopurine nucleoside analogues
Scheme 24
Scheme 24
A possible catalytic cycle for the Cu(OTf)2/PIDA-mediated cyclization
Scheme 25
Scheme 25
Comparison of the reactivity of disilyl-protected N6-phenyl 2′-deoxyadenosine to triacetyl-protected N6-phenyl adenosine analogue
Scheme 26
Scheme 26
Compounds synthesized using PIDA in HFIP, at room temperature
Scheme 27
Scheme 27
A possible mechanistic pathway for the cyclization reaction with PIDA in HFIP
Scheme 28
Scheme 28
Two possible cyclization modes with N6-biarylyl adenine nucleoside derivatives

Similar articles

References

    1. Herdewijn P, editor. Biochemistry, Biotechnology and Medicine. Wiley-VCH; Weinheim, Germany: 2008. Modified Nucleosides.
    1. Vaghefi M, editor. Nucleoside Triphosphates and Their Analogs: Chemistry, Biotechnology, and Biological Applications. CRC Press; Boca Raton, FL: 2005.
    1. Chu CK, editor. Antiviral Nucleosides: Chiral Synthesis and Chemotherapy. Elsevier; Amsterdam: 2003.
    1. Jordheim LP, Durantel D, Zoulim F, Dumontet C. Nature Rev Drug Discov. 2013;12:447–464. - PubMed
    1. Damaraju VL, Damaraju S, Young JD, Baldwin SA, Mackey J, Sawyer MB, Cass CE. Oncogene. 2003;22:7524–7536. - PubMed

LinkOut - more resources